Pfizer-Boulder (formerly Array BioPharma) is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, and successfully launched approved drugs BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the treatment of patients with BRAF mutated melanoma . These products have also been granted Breakthrough Therapy Designation by the FDA for BRAF mutated CRC.
With more than 300 days a year of sunshine, Boulder-Colorado is a paradise in the West! Hikers, bikers, foodies, beer enthusiasts, art and theater lovers, and more feel right at home here. Visit https://www.bouldercoloradousa.com/ to discover what we love about Boulder.
ROLE SUMMARY
We seek an exceptional scientist with demonstrated experience employing steady state and/or biophysical techniques to characterize the interaction of small molecule inhibitors with their protein targets. This person will be responsible for assay development, screening, lead characterization and lead optimization in a collaborative team environment, working closely with structural biologists, protein chemists, computational and medicinal chemists. The candidate will take a functional leadership role on these project teams in a fast-paced drug discovery environment. Additionally, the candidate will mentor other members of the group in mechanistic enzymology.
ROLE RESPONSIBILITIES
* Independently lead enzymology effort on project team(s) with assay development, HTS, assay support and mechanism of action studies.
* Document and provide regular, written and/or verbal reports of experimental findings as well as offering strategic guidance to the project team(s).
* Mentor more junior Enzymology Group members and other Biology Department members in mechanistic enzymology.
* Solve complex problems in mechanistic enzymology related to drug discovery.
* Present at group meetings, global project team meetings, and site meetings
* Collaborate with medicinal chemists, computational chemists, structural biologists, and cell biologists to pursue the most promising small molecule compounds through candidate identification and selection.
* May supervise research associates and/or scientists.
BASIC QUALIFICATIONS
* Ph.D. in biochemistry or related field with 5+ years of postdoctoral experience and relevant industry experience.
* Advanced knowledge of mechanistic enzymology and biophysical technologies supported by peer-reviewed publications.
* Demonstrated expertise determining enzyme mechanisms and inhibitor MOAs using steady-state kinetics and related technologies.
* Ability to manage an independent research program with no supervision including designing, planning, executing, interpreting and documenting experiments.
* Strong organizational and interpersonal skills.
* Ability to work well with team members across functional areas.
* Self-motivation with a desire to learn.
* Demonstrated scientific excellence with attention to detail.
* Ability to organize and communicate complex data sets in a clear and concise manner to key stakeholders from diverse backgrounds.
* Ability to represent discovery teams and communicate goals/deliverables to senior management and/or governance committees.
PREFERRED QUALIFICATIONS
* Small molecule drug discovery experience in an industrial setting.
* Experience in laboratory robotics and high throughput screening.
* Experience with general biochemical and kinetic-based assay technologies (e.g., FI, FP, TR-FRET, LanthaScreen, AlphaScreen, luminescence).
* Experience in biophysical techniques for characterizing interactions between proteins and ligands.
* Experience in mentoring and/or leading Ph.D. level and non-Ph.D. level scientists.
* Experience in curve-fitting, statistics and assay optimization (DOE).
* Proficiency with Microsoft Office and associated applications (e.g., XLfit), Spotfire, Design-Expert.
OTHER JOB DETAILS
* Eligible for Employee Referral Bonus
* Eligible for Relocation Package
LI-PFE
The annual base salary for this position ranges from $90,500 to $150,900. In addition, this position offers an annual bonus with a target of 1% of the base salary and eligibility to participate in our share based long term incentive program. Benefits offered include a retirement savings plan, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage in accordance with the terms and conditions of the applicable plans.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Research and Development
LI-PFE
New York, New York
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names.
Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.